PCI Biotech Holding ASA (PCIBNOK)

Currency in NOK
1.46
-0.02(-1.35%)
Closed·
Trading near 52-week Low
Earnings results expected in 0 days
PCIBNOK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.461.49
52 wk Range
1.461.50
Key Statistics
Prev. Close
1.46
Open
1.49
Day's Range
1.46-1.49
52 wk Range
1.46-1.5
Volume
100
Average Volume (3m)
216
1-Year Change
-18.89%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PCIBNOK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

PCI Biotech Holding ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

PCI Biotech Holding ASA Company Profile

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform. The company’s technology platform consists of a proprietary small molecule photosensitiser and a light source; and develops photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing, as well as photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.

Compare PCIBNOK to Peers and Sector

Metrics to compare
PCIBNOK
Peers
Sector
Relationship
P/E Ratio
0.0x−1.9x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.4x2.6x
Price / LTM Sales
0.0x6.1x3.3x
Upside (Analyst Target)
0.0%52.7%40.3%
Fair Value Upside
Unlock12.7%5.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PCIBNOK Income Statement

FAQ

What Stock Exchange Does PCI Biotech Holding ASA Trade On?

PCI Biotech Holding ASA is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for PCI Biotech Holding ASA?

The stock symbol for PCI Biotech Holding ASA is "PCIBNOK."

What Is the PCI Biotech Holding ASA Market Cap?

As of today, PCI Biotech Holding ASA market cap is 55.80M.

What Is PCI Biotech Holding ASA's Earnings Per Share (TTM)?

The PCI Biotech Holding ASA EPS (TTM) is -0.44.

When Is the Next PCI Biotech Holding ASA Earnings Date?

PCI Biotech Holding ASA will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is PCIBNOK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PCI Biotech Holding ASA Stock Split?

PCI Biotech Holding ASA has split 0 times.

How Many Employees Does PCI Biotech Holding ASA Have?

PCI Biotech Holding ASA has 5 employees.

What is the current trading status of PCI Biotech Holding ASA (PCIBNOK)?

As of 16 Aug 2025, PCI Biotech Holding ASA (PCIBNOK) is trading at a price of 1.46, with a previous close of 1.46. The stock has fluctuated within a day range of 1.46 to 1.49, while its 52-week range spans from 1.46 to 1.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.